Elevance Health, Inc. (NYSE: ELV) had its "neutral" rating re-affirmed by analysts at Robert W. Baird. They now have a $529.00 price target on the stock, down previously from $625.00.
LowReport
Elevance Health, Inc. (NYSE: ELV) had its "neutral" rating re-affirmed by analysts at Robert W. Baird. They now have a $529.00 price target on the stock, down previously from $625.00.
Elevance Health, Inc. (NYSE: ELV) had its price target raised by analysts at Truist Financial Co. from $480.00 to $510.00. They now have a "buy" rating on the stock.
LowReport
Elevance Health, Inc. (NYSE: ELV) had its price target raised by analysts at Truist Financial Co. from $480.00 to $510.00. They now have a "buy" rating on the stock.
Amerigroup DC and DC Connected Care Network Announce Initiative to Transform Washington D.C.'s Health Outcomes Through Value-Based Care [Yahoo! Finance]
LowReport
Amerigroup DC and DC Connected Care Network Announce Initiative to Transform Washington D.C.'s Health Outcomes Through Value-Based Care [Yahoo! Finance]
Elevance Health, Inc. (NYSE: ELV) had its price target raised by analysts at Mizuho from $455.00 to $505.00. They now have an "outperform" rating on the stock.
LowReport
Elevance Health, Inc. (NYSE: ELV) had its price target raised by analysts at Mizuho from $455.00 to $505.00. They now have an "outperform" rating on the stock.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: